|
25
|
116
|
5fo2A |
Structure of human transthyretin mutant a108i |
|
30
|
116
|
5e4oA |
Human transthyretin (ttr) complexed with (z)-((3,4-dichloro-phenyl)-methyleneaminooxy)-acetic acid |
|
23
|
115
|
5ezpA |
Human transthyretin (ttr) complexed with 4-hydroxy-chalcone |
|
27
|
116
|
5e4aA |
Human transthyretin (ttr) complexed with (2,7-dichloro-fluoren-9-ylideneaminooxy)-acetic acid. |
|
27
|
116
|
5en3A |
Crystal structure of human transthyretin in complex with luteolin-cl at 1.25 a resolution |
|
28
|
116
|
5e23A |
Human transthyretin (ttr) complexed with (2,7-dibromo-fluoren-9-ylideneaminooxy)-acetic acid |
|
27
|
116
|
5dwpA |
Crystal structure of human transthyretin (ttr) processed with the crystaldirect automated mounting and cryo-cooling technology |
|
29
|
116
|
5dejA |
Transthyretin natural mutant a19d |
|
30
|
116
|
5aktA |
Transthyretin binding heterogeneity and anti-amyloidogenic activity of natural polyphenols and their metabolites: resveratrol-4'-o- glucuronide |
|
29
|
116
|
5akvA |
Transthyretin binding heterogeneity and anti-amyloidogenic activity of natural polyphenols and their metabolites: genistein-7-o- glucuronide |
|
27
|
116
|
5al0A |
Transthyretin binding heterogeneity and anti-amyloidogenic activity of natural polyphenols and their metabolites: resveratrol-3-o-sulfate |
|
28
|
116
|
5al8A |
Transthyretin binding heterogeneity and anti-amyloidogenic activity of natural polyphenols and their metabolites: daidzein-7-o- glucuronide |
|
30
|
116
|
5aksA |
Transthyretin binding heterogeneity and anti-amyloidogenic activity of natural polyphenols and their metabolites: resveratrol-3-o- glucuronide |
|
25
|
116
|
4ydnA |
High resolution crystal structure of human transthyretin bound to ligand and conjugates of 4-(5-(3,5-dichloro-4-hydroxyphenyl)-1,3,4-oxadiazol-2-yl)phenyl fluorosulfate |
|
27
|
116
|
4y9gA |
Crystal structure of v30m mutated transthyretin in complex with 3-isomangostin |
|
25
|
115
|
4y9cA |
Crystal structure of v30m mutated transthyretin with bromide in complex with alpha-mangostin |
|
30
|
116
|
5clzA |
X-ray structure of ttr mutant - t119m at 1.22a resolution |
|
25
|
116
|
4ydmA |
High resolution crystal structure of human transthyretin bound to ligand and conjugates of 3-(5-(3,5-dichloro-4-hydroxyphenyl)-1,3,4-oxadiazol-2-yl)phenyl fluorosulfate |
|
26
|
115
|
4y9fA |
Crystal structure of v30m mutated transthyretin with bromide in complex with gamma-mangostin |
|
29
|
116
|
4y9eA |
Crystal structure of v30m mutated transthyretin in complex with gamma-mangostin |
|
25
|
116
|
5clxA |
X-ray structure of perdeuterated ttr mutant - s52p at 1.28a resolution |
|
29
|
116
|
4y9bA |
Crystal structure of v30m mutated transthyretin in complex with alpha-mangostin |
|
25
|
116
|
5cnhA |
X-ray structure of perdeuterated wild-type ttr at 1.42a resolution |
|
26
|
115
|
4wo0A |
Crystal structure of transthyretin in complex with apigenin |
|
24
|
115
|
4wnsA |
Crystal structure of transthyretin complexed with pterostilbene |
|
28
|
116
|
4wnjA |
Crystal structure of transthyretin-quercetin complex |
|
28
|
115
|
4tm9A |
Crystal structure of human transthyretin thr119trp mutant |
|
27
|
115
|
4tl4A |
Crystal structure of human transthyretin val30met mutant |
|
27
|
116
|
4tqpA |
Human transthyretin (ttr) complexed with (r)-3-(9h-fluoren-9-ylideneaminooxy)-2-methyl-n-(methylsulfonyl) propionamide in a dual binding mode |
|
27
|
116
|
4tq8A |
Dual binding mode for 3-(9h-fluoren-9-ylideneaminooxy)propanoic acid binding to human transthyretin (ttr) |
|
25
|
116
|
4tnfA |
Crystal structure of human transthyretin lys15trp mutant |
|
28
|
115
|
4tneA |
Crystal structure of human transthyretin thr119tyr mutant |
|
30
|
117
|
4tqhA |
Human transthyretin (ttr) complexed with 3-(9h-fluoren-9-ylideneaminooxy)ethanoic acid |
|
27
|
116
|
4tl5A |
Crystal structure of human transthyretin ser85pro mutant |
|
27
|
115
|
4tngA |
Crystal structure of human transthyretin thr119met mutant |
|
26
|
115
|
4tkwA |
Crystal structure of human transthyretin leu55pro mutant |
|
27
|
116
|
4tqiA |
Human transthyretin (ttr) complexed with 3-(9h-fluoren-9-ylideneaminooxy)propanoic acid in a dual binding mode |
|
27
|
114
|
4tluA |
Crystal structure of human transthyretin ala108trp mutant |
|
26
|
115
|
4tlsA |
Crystal structure of human transthyretin glu92pro mutant |
|
28
|
114
|
4tltA |
Crystal structure of human transthyretin |
|
27
|
115
|
4tlkA |
Crystal structure of human transthyretin ser85pro/glu92pro mutant |
|
29
|
116
|
4qyaA |
Crystal structure of human transthyretin variant v30m in complex with luteolin |
|
26
|
115
|
4qrfA |
Crystal structure of v30m mutant human transthyretin complexed with caffeic acid phenethyl ester |
|
25
|
116
|
4qxvA |
Crystal structure of human transthyretin in complex with luteolin at 1.1 a resolution |
|
27
|
116
|
4pvnA |
Neutron structure of human transthyretin (ttr) at room temperature to 2.3a resolution (monochromatic) |
|
28
|
117
|
4pmeA |
Human transthyretin (ttr) complexed with ferulic acid and curcumin. |
|
27
|
118
|
4q14A |
Crystal structure of 5-hydroxyisourate hydrolase from brucella melitensis |
|
28
|
116
|
4pvlA |
X-ray structure of human transthyretin (ttr) at room temperature to 1.9a resolution |
|
27
|
116
|
4pwgA |
Crystal structure of v30m mutant human transthyretin complexed with caffeic acid ethyl ester |
|
26
|
115
|
4pwfA |
Crystal structure of v30m mutant human transthyretin complexed with ferulic acid phenethyl ester |
